| Ligand Announces Fourth Quarter and Full Year 2008 Consolidated ... - Trading Markets (press release) |
|
|
... with anemia of chronic disease, as well as to patients treated with ESA (erythropoietin stimulating agent) who may have chronic renal disease or cancer. ... |